New insights into the management of severe sepsis and septic shock

More documents

Recommendations

Info

Empirical antibiotic combinations Intabdominal infections:piperacillin/tazobactam (or a carbopenem)plus an aminogycoside Skin and soft tissue infection: clindamycinplus vancomycin (or linezolid) Unknown source: meropenem (orpiperacilline/tazobactam) plus anaminoglycoside (gentamicine)
Source controlMeasures to eradicate the source of theinfection is an integral component of therapy.This may include: Abscess drainage Debridement of devitalized infected tissue Removal of infected prosthesis
Page 1 and 2: Surviving Sepsis Campaign UpdatedGu
Page 3 and 4: Guide to Recommendations’ Strengt
Page 5 and 6: Definitions Severe sepsis is define
Page 7: Prognosis More than half of all sep
Page 10 and 11: Early haemodynamic optimization(res
Page 12 and 13: Early haemodynamic optimization(res
Page 14 and 15: Components of EGDT(resuscitation bu
Page 16 and 17: Surviving Sepsis: New monitoringrec
Page 18 and 19: Surviving Sepsis: New Fluid Resusci
Page 20 and 21: Surviving Sepsis: New Recommendatio
Page 22 and 23: Inotropic therapy After adequate vo
Page 24 and 25: Decreasing oxygen consumption When
Page 27: Empirical antibiotic combinations P
Page 31 and 32: Drotrecogin alfa (activated protein
Page 33 and 34: Systemic corticosteroids Despite mo
Page 35 and 36: Systemic corticosteroidsSumming up,
Page 37: Surviving Sepsis guidelines regardi

New insights into the management of severe sepsis and septic shock

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?